×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MLTX – moonlake immunotherapeutics - class a ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MLTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/30
08:43 am
mltx
MoonLake Immunotherapeutics (MLTX) had its "buy" rating reaffirmed by BTIG Research. They now have a $30.00 price target on the stock.
Medium
Report
MoonLake Immunotherapeutics (MLTX) had its "buy" rating reaffirmed by BTIG Research. They now have a $30.00 price target on the stock.
3/28
03:45 pm
mltx
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting [Yahoo! Finance]
Low
Report
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting [Yahoo! Finance]
3/28
03:00 pm
mltx
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Low
Report
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
3/23
08:42 am
mltx
MoonLake Immunotherapeutics (MLTX) was upgraded by Wolfe Research from "underperform" to "outperform". They now have a $24.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (MLTX) was upgraded by Wolfe Research from "underperform" to "outperform". They now have a $24.00 price target on the stock.
3/19
08:43 am
mltx
MoonLake Immunotherapeutics (MLTX) was upgraded by Rothschild & Co Redburn from "neutral" to "buy". They now have a $40.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (MLTX) was upgraded by Rothschild & Co Redburn from "neutral" to "buy". They now have a $40.00 price target on the stock.
3/16
08:06 pm
mltx
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? [Yahoo! Finance]
Low
Report
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? [Yahoo! Finance]
3/2
11:54 am
mltx
MoonLake Immunotherapeutics (MLTX) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have a "sector perform" rating on the stock.
Neutral
Report
MoonLake Immunotherapeutics (MLTX) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have a "sector perform" rating on the stock.
3/2
10:38 am
mltx
Goldman Questions MoonLake Immunotherapeutics' (MLTX) Sonelokimab Approval Odds Despite Pipeline Update [Yahoo! Finance]
Low
Report
Goldman Questions MoonLake Immunotherapeutics' (MLTX) Sonelokimab Approval Odds Despite Pipeline Update [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/25/2026
06:12 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
0.9%
moonlake immunotherapeutics - class a ordinary shares
11/5/2025
07:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
4.7%
moonlake immunotherapeutics - class a ordinary shares
8/5/2025
07:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
1.5%
moonlake immunotherapeutics - class a ordinary shares
5/12/2025
04:00 pm
mltx
moonlake immunotherapeutics - class a ordinary shares
BEAT
Report
-4.1%
moonlake immunotherapeutics - class a ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
04:10 pm
mltx
Form 4 MoonLake Immunotherapeut For: Apr 14 Filed by: Bodenstedt Matthias
Medium
Report
Form 4 MoonLake Immunotherapeut For: Apr 14 Filed by: Bodenstedt Matthias
4/14
05:56 pm
mltx
Form 4 MoonLake Immunotherapeut For: Apr 10 Filed by: Santos da Silva Jorge
Medium
Report
Form 4 MoonLake Immunotherapeut For: Apr 10 Filed by: Santos da Silva Jorge
4/10
06:07 pm
mltx
Form 4 MoonLake Immunotherapeut For: Apr 09 Filed by: Bodenstedt Matthias
Low
Report
Form 4 MoonLake Immunotherapeut For: Apr 09 Filed by: Bodenstedt Matthias
4/10
09:56 am
mltx
Form 144 MoonLake Immunotherapeut Filed by: Santos da Silva Jorge
Medium
Report
Form 144 MoonLake Immunotherapeut Filed by: Santos da Silva Jorge
4/9
04:02 pm
mltx
Form 144 MoonLake Immunotherapeut Filed by: Bodenstedt Matthias
Medium
Report
Form 144 MoonLake Immunotherapeut Filed by: Bodenstedt Matthias
4/2
04:48 pm
mltx
Form 4 MoonLake Immunotherapeut For: Mar 31 Filed by: BVF II GP LLC
Low
Report
Form 4 MoonLake Immunotherapeut For: Mar 31 Filed by: BVF II GP LLC
4/2
04:44 pm
mltx
Form SCHEDULE 13D/A MoonLake Immunotherapeut Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13D/A MoonLake Immunotherapeut Filed by: BIOTECHNOLOGY VALUE FUND L P
3/31
09:18 pm
mltx
Form 144 MoonLake Immunotherapeut Filed by: BVF PARTNERS L P/IL
High
Report
Form 144 MoonLake Immunotherapeut Filed by: BVF PARTNERS L P/IL
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: